About us
Services & Solutions
Chemistry Drug Metabolism and Pharmacokinetics (DMPK) Discovery Biology Oncology Pharmacology Biologics
Medicinal Chemistry Parallel Synthesis Peptide Chemistry Computational Chemistry Synthetic Chemistry Analytical Chemistry Scale Up Chemistry
In Vivo PK and TK In Vitro ADME Bioanalytical Service Exploratory Toxicity In Rodents, Dogs and Monkeys Large Molecules Capabilities Bioanalytical Instruments
Fragment Based Drug Discovery (FBDD) Biochemical Assays Cellular Assays Protein Science Assay Technologies Biophysics SPR Safety Pharmacology Screening Services Key Instruments
PDX CDX Orthotopic Models Syngeneic Models Humanized Mouse Models CAR-T and CAR-NK Mouse Models In Vitro Assays
Immunology Inflammation Metabolic NASH/MASH Respiratory Neuroscience
Systematic Antibody Discovery Service
Process R&D Scale Up Synthesis DS Manufacturing
Flow Chemistry Sugar Chemistry Peptide Chemistry Preparative Purification Capacity Process Safety Assessment
Synthetic and Scale Up Chemistry
Kilo and Pilot Scale Production RSM and Intermediates Manufacturing QA EHS
Pre-Formulation Formulation, Analytical and Process Development Drug Product Manufacturing
Bioavailability Enhancement Modified Release
Commercial Manufacturing
Platforms
News & Resources
Careers
Contact us
×

news

Company News Events Insights Webinars Virtual Tours

BioDuro-Sundia Launches New Compound Management Center, Strengthening Drug Discovery Services

IRVINE, CALIF., October 1, 2024 – BioDuro-Sundia, a leading global contract research, development and manufacturing organization (CRDMO), today announced the launch of a new Compound Management Center
October 01, 2024

BioDuro-Sundia Appoints Dr. Armin Spura as New Chief Executive Officer

Irvine, CA, USA – September 16th – BioDuro-Sundia, a leading Contract Research, Development, and Manufacturing Organization (CRDMO), is pleased to announce the appointment of Dr. Armin Spura as its ne
September 16, 2024

Two Sites from BioDuro-Sundia Receive ISO 27001 Certification

Irvine, CA, USA, September 9, 2024 – BioDuro-Sundia announced its two sites, Shanghai Waigaoqiao site and Jiangsu site in China, has officially received ISO 27001 certification, meeting the high globa
September 09, 2024

BioDuro-Sundia Wins Premium Global Partner at CPHI China Pharma Awards 2024

BioDuro-Sundia, a trusted global Contract Research, Development, and Manufacturing Organization (CRDMO) and an Advent International portfolio company, announced that it has been named "Premium Global Partner" at CPHI China Pharma Awards 2024.
June 20, 2024

BioDuro-Sundia’s Partner, DigmBio Announced IND Clearance from Korea MFDS for its Selective PARP1 Inhibitor DM5167

BioDuro-Sundia’s Partner, DigmBio Announced IND Clearance from Korea MFDS for its Selective PARP1 Inhibitor DM5167 | BioDuro-Sundia | Moving You Forward
March 26, 2024
Total 88 12345678...1718
BIOSECURE Act Concerns?
We're a US-owned CRDMO partner offering speed, quality and cost savings, but without any geopolitical risks.
View more
Subscribe to BioDuro-Sundia
Receive our newsletter and information on upcoming events
Your trusted partner from drug discovery and
development to commercialization

Home

About us

Services & Solutions

Platforms

News & Resources

Careers

Contact us

Explore

Discovery

Drug Substance

Drug Product

© 2023 BioDuro-Sundia. All rights reserved
Terms of Use Privacy Policy
We use necessary cookies to ensure our website functions properly and to keep it secure. These necessary cookies must be enabled. By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. You can personalize or withdraw your consent at any moment by clicking on the link "Cookies Settings". For more information on how we use cookies, including the total lifespan of cookies and the identity of third parties intervening on our website, please consult the Privacy Notice available in the site footer.
Accept all